Statins—Beyond Their Use in Hypercholesterolemia: Focus on the Pediatric Population
Children · 17.01.2024 · 11 (1) · 117
DOI: 10.3390/children11010117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 17.01.2024. Verfasst von Elena Lia Spoiala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, "Gr. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Statins are a class of medications primarily used in adults to lower cholesterol levels and reduce the risk of cardiovascular events. However, the use of statins in children is generally limited and carefully considered despite the well-documented anti-inflammatory, anti-angiogenic, and pro-apoptotic effects, as well as their effect on cell signaling pathways. These multifaceted effects, known as pleiotropic effects, encompass enhancements in endothelial function, a significant reduction in oxidative stress, the stabilization of atherosclerotic plaques, immunomodulation, the inhibition of vascular smooth muscle proliferation, an influence on bone metabolism, anti-inflammatory properties, antithrombotic effects, and a diminished risk of dementia. In children, recent research revealed promising perspectives on the use of statins in various conditions including neurological, cardiovascular, and oncologic diseases, as well as special situations, such as transplanted children. The long-term safety and efficacy of statins in children are still subjects of ongoing research, and healthcare providers carefully assess the individual risk factors and benefits before prescribing these medications to pediatric patients. The use of statins in children is generally less common than in adults, and it requires close monitoring and supervision by healthcare professionals. Further research is needed to fully assess the pleiotropic effects of statins in the pediatric population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, "Gr. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Pediatric Cardiology, "Marie Curie" Emergency Children's Hospital, 041451 Bucharest, Romania.
- Cardio-Thoracic Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Clinical Emergency Hospital, 014461 Bucharest, Romania.
- "Diabnutrimed" Medical Center, 020359 Bucharest, Romania.
ORCID-Profile: Elena Lia Spoiala, Eliza Cinteza, Radu Vatasescu, Stefana Maria Moisa
Zitieren
APA
Spoiala, E. L., Cinteza, E., Vatasescu, R., Vlaiculescu, M. V., & Moisa, S. M. (2024). Statins—Beyond Their Use in Hypercholesterolemia: Focus on the Pediatric Population. Children, 11(1), 117. https://doi.org/10.3390/children11010117
Vancouver
Spoiala EL, Cinteza E, Vatasescu R, Vlaiculescu MV, Moisa SM. Statins—Beyond Their Use in Hypercholesterolemia: Focus on the Pediatric Population. Children. 2024;11(1):117. doi:10.3390/children11010117
BibTeX
@article{Spoiala2024,
author = {Spoiala, Elena Lia and Cinteza, Eliza and Vatasescu, Radu and Vlaiculescu, Mihaela Victoria and Moisa, Stefana Maria},
title = {Statins—Beyond Their Use in Hypercholesterolemia: Focus on the Pediatric Population},
journal = {Children},
year = {2024},
volume = {11},
number = {1},
pages = {117},
doi = {10.3390/children11010117}
}
EUVIMED